Stay updated on Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.

Latest updates to the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page
- Check3 days agoChange DetectedFooter now shows Revision: v3.6.5 (previously v3.6.4). This indicates a minor site update without changes to the study information presented on the page.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new revision label, Revision: v3.6.4, was added and the previous label Revision: v3.6.3 was removed. This signals a small backend/page update without altering core content.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a new internal update to the page.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page's revision stamp has been updated from v3.6.0 to v3.6.2. This reflects a minor backend/content refresh and does not alter the study details or user-facing content.SummaryDifference0.0%

- Check61 days agoChange DetectedThe study page now indicates that recruitment has ended ('No longer looking for participants'), clarifying enrollment status. There are also minor UI/content updates, including labeling changes to Intervention/Treatment and the addition of guidance/navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'.SummaryDifference0.3%

- Check68 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor platform update.SummaryDifference0.0%

Stay in the know with updates to Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.